Afatinib Intermediate
High-Purity Afatinib Intermediate for Research and API Synthesis
Zhejiang ShiLai Bioengineering Co., Ltd. offers high-quality Afatinib intermediate, a key building block for EGFR tyrosine kinase inhibitor development. Our Afatinib intermediate is manufactured under strict quality control standards, ensuring high purity, consistent batch-to-batch performance, and reliability for research, drug development, and API synthesis applications.